Literature DB >> 9258002

The effect of time delays on the dynamics of avascular tumor growth.

H M Byrne1.   

Abstract

During avascular tumor growth, the balance between cell proliferation and cell loss determines whether the colony expands or regresses. Mathematical models describing avascular tumor growth distinguish between necrosis and apoptosis as distinct cell loss mechanisms: necrosis occurs when the nutrient level is insufficient to sustain the cell population, whereas apoptosis can occur in a nutrient-rich environment and usually occurs when the cell exceeds its natural lifespan. Experiments suggest that changes in the proliferation rate can trigger changes in apoptotic cell loss and that these changes do not occur instantaneously: they are mediated by growth factors expressed by the tumor cells. In this paper, we consider two ways of modifying the standard model of avascular tumor growth by incorporating into the net proliferation rate a time-delayed factor. In the first case, the delay represents the time taken for cells to undergo mitosis. In the second case, the delay represents the time for changes in the proliferation to stimulate compensatory changes in apoptotic cell loss. Numerical and asymptotic techniques are used to show how a tumor's growth dynamics are affected by including such delay terms. In the first case, the size of the delay does not affect the limiting behavior of the tumor: it simply modifies the details of its evolution. In the second case, the delay can alter the tumor's evolution dramatically. In certain cases, if the delay exceeds a critical value, defined in terms of the system parameters, then the underlying radially symmetric steady state is unstable with respect to time-dependent perturbations. (For smaller delays, this steady state is stable). Using the delay as a measure of the speed with which a tumor adapts to changes in its structure, we infer that, for the second case, a highly responsive tumor (small delay) has a better chance of surviving than does a less-responsive tumor (large delay). We also conclude that the tumor's evolution depends crucially on the manner and speed with which it adapts to changes in its surroundings and composition.

Entities:  

Mesh:

Year:  1997        PMID: 9258002     DOI: 10.1016/s0025-5564(97)00023-0

Source DB:  PubMed          Journal:  Math Biosci        ISSN: 0025-5564            Impact factor:   2.144


  8 in total

1.  Detection of breast cancer. Clinical breast examination is not an acceptable alternative to mammography.

Authors:  C J de Wolf
Journal:  BMJ       Date:  2001-03-31

2.  Oscillations in growth of multicellular tumour spheroids: a revisited quantitative analysis.

Authors:  A S Gliozzi; C Guiot; R Chignola; P P Delsanto
Journal:  Cell Prolif       Date:  2010-08       Impact factor: 6.831

3.  Nonlinear modelling of cancer: bridging the gap between cells and tumours.

Authors:  J S Lowengrub; H B Frieboes; F Jin; Y-L Chuang; X Li; P Macklin; S M Wise; V Cristini
Journal:  Nonlinearity       Date:  2010

4.  The universal dynamics of tumor growth.

Authors:  Antonio Brú; Sonia Albertos; José Luis Subiza; José López García-Asenjo; Isabel Brú
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

5.  Global practical tracking by output feedback for nonlinear systems with unknown growth rate and time delay.

Authors:  Xuehua Yan; Xinmin Song
Journal:  ScientificWorldJournal       Date:  2014-09-03

6.  Steady-state analysis of necrotic core formation for solid avascular tumors with time delays in regulatory apoptosis.

Authors:  Fangwei Zhang; Shihe Xu
Journal:  Comput Math Methods Med       Date:  2014-10-13       Impact factor: 2.238

7.  A Time-Delayed Mathematical Model for Tumor Growth with the Effect of a Periodic Therapy.

Authors:  Shihe Xu; Xiangqing Wei; Fangwei Zhang
Journal:  Comput Math Methods Med       Date:  2016-05-05       Impact factor: 2.238

8.  Staurosporine induces apoptosis in pancreatic carcinoma cells PaTu 8988t and Panc-1 via the intrinsic signaling pathway.

Authors:  Manuela Malsy; Diane Bitzinger; Bernhard Graf; Anika Bundscherer
Journal:  Eur J Med Res       Date:  2019-01-28       Impact factor: 2.175

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.